MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, (GLOBE ...

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

(per RECIST v1.1) at the 100 mg APR-1051 dose level in heavily pretreated gastrointestinal and gynecologic malignanciesDisease stabilization observed in patients with tumors harboring mutations ...
TipRanks on MSN

Immutep presents two posters at ESMO on changing landscape for 1L NSCLC

Immutep (IMMP) announces two poster presentations at the European Society for Medical Oncology Congress 2025 highlight the Company’s focus on ...
KCEN-TV on MSN

Trial date set for accused McGregor shooter

A trial date has been set for the man accused of shooting and killing five people in McGregor in 2022. MCGREGOR, Texas — A ...